In addition to classical biochemical signaling cascades, TGF-β in the tumor microenvironment activates pro-tumor and anti-inflammatory mechanotransduction pathways through ECM remodeling, cytoskeletal alterations, and maintenance of DNA damage. Here, TGFB1 is linked to neoplasm.